2009 seminar schedule

ABOUT AFRRI | A–Z INDEX | CONTACT US

EMERGENCY RESPONSE

AFRRI 50th Anniversary Symposia

Biodosimetry Tools

Emergency Response Resources
Advisory team
Other resources

Managing Radiation Casualties
POLICIES
  Depleted uranium
  Potassium iodide
  Prussian blue
PUBLICATIONS
  Radiation patient treatment
  Managing radiological casualties
  Response to nuclear detonation
      • 1st Edition (Jan 2009)
      • 2nd Edition (Jun 2010)
  NCRP recommendations
  Consequences of nuclear warfare

Medical Effects of Ionizing Radiation
  In-person course
  Online course
  Schedule, fees, registration
  Course resources

Product Quick List
  Exposure assessment tools
  Forms
  Guidance

Publications
  Books/book chapters
  Contract reports/films
  Journal articles/supplements
  Reports/report chapters
  Scientific reports
  Special publications
  Technical reports

Register AFRRI Products

Research Programs
  Biological dosimetry
  Radiation combined injury
  Internal contamination/toxic metals
  Radiation countermeasures

2013 AFRRI Seminars

USU Dept. of Radiation Biology

You are here: HOME > Seminars > 2009 seminar schedule
2009 AFRRI Seminars
Jump to: 2013 \| 2012 \| 2011 \| 2010 \| 2009 \| 2008 \| 2007 \| 2006 \| 2005 \| 2004 \| 2003
Venue
Time: 11 a.m. to 12 noon (unless otherwise noted) each Friday Place: AFRRI Conference Room, unless otherwise indicated.
Directions to AFRRI \| Base map \| Security, base access, parking
Seminars are presented by AFRRI researchers and other members of the scientific community. While some seminars are open to the public, others are limited to specific audiences. Any exceptions to time, place, and admittance are noted with each item. We do not record or distribute information presented in our Seminar Program. However, where available, references to related information are provided with the seminar title.
2009 seminar schedule
Friday, December 18: Natalia I. Ossetrova, PhD, Research Biologist, Biological Dosimetry, AFRRI: Early-phase and organ-specific protein biomarkers for radiation dose and injury assessment in nonhuman primate TBI model. Related information: The use of discriminant analysis for evaluation of early-response multiple biomarkers of radiation exposure using non-human primate 6-Gy whole-body radiation model. Radiation Measurements 42:1158–1163, 2007. Multiple blood-proteins approach for early-response exposure assessment using an in vivo murine radiation model. Intl J Rad Biol. 85: 837–850, 2009. Amylase and blood cell-count hematological radiation-injury biomarkers in a rhesus monkey radiation model—use of multiparameter and integrated biological dosimetry. Radiation Measurements 42: 1164–1170, 2007. Friday, December 11: Rupak Pathak, PhD, Post-Doctoral Research Associate, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI): PCC and micronuclei induction in human lymphocytes after gamma irradiation. Related information: Differential radio-sensitivities of human chromosomes 1 and 2 in one donor in interphase- and metaphase-spreads after ⁶⁰Co gamma-irradiation. BMC Med Phys. 9:6, 2009. Cell killing, nuclear damage and apoptosis in Chinese hamster V79 cells after irradiation with heavy-ion beams of (16)O, (12)C and (7)Li. Mutat Res. 632:58–68, 2007. Response to high LET radiation 12C (LET, 295 keV/microm) in M5 cells, a radio resistant cell strain derived from Chinese hamster V79 cells. Int J Radiat Biol. 83:53–63, 2007. Friday, December 4: Saibal Dey, PhD, Associate Professor, Department of Biochemistry and Molecular Biology, F. Edward Hébert School of Medicine, USUHS: The human multidrug transporter: In search of an Achilles heel. Related information: Low concentration of arsenic induce caspase-3 mediated head kidney macrophage apoptosis with JNK-p38 activation in Claris batrachas. Toxicol Appl Pharmacol. 241:329–328, 2009. Gomisin A alters substrate interaction and reverses P-glycoprotein mediated multidrug resistance in HepG2-DR cells. Biochem Pharmacol. 72:824–837, 2006. Biochemical and pharmacological properties of an allosteric modulator site of human P-glycoprotein (ABCB1). Biochem Pharmacol. 72:145–155, 2006. Friday, November 20: Adarsh Ramakumar, PhD, Senior Bioinformatics & Biomedical Analyst, Biological Dosimetry Program, AFRRI: AI-based high throughput dicentric analysis at AFRRI: Crossing the human analytical limitations; aid triage during radiation mass casualty. Related information: Differential radio-sensitivities of human chromosomes 1 and 2 in one donor in interphase- and metaphase-spreads after ⁶⁰Co gamma-irradiation. BMC Med Phys. 16:9:6, 2009. Complete genome of the mutualistic, N2-fixing grass endophyte Azoarcus sp. strain BH72. Nat Biotechnol. 24:1385–91, 2006. Friday, November 6: Mang Xiao, MD, Research Biologist, Radiation Countermeasures Program, AFRRI: Delta-tocotrienol enhances mouse survival after gamma-irradiation and protects mouse and human hematopoietic progenitors through Erk/mTOR signaling. Related information: Pharmacological countermeasures for the acute radiation syndrome. Curr Mol Pharmacol. 2:122–133, 2009. Role of NF-kappaB in hematopoietic niche function of osteoblasts after radiation injury. Exp Hematol. 37:52–64, 2009. 5-Androstenediol promotes survival of gamma-irradiated human hematopoietic progenitors through induction of NF-kappaB activation and G-CSF expression. Mol Pharmacol. 72:370–379, 2007. Friday, October 30 (10–11 a.m.): Nikolai Gorbunov, PhD, Research Associate Professor, Henry M. Jackson Foundation (Combined Injury Program, AFRRI): A pattern of intestinal innate host defense mechanisms mediated by crypt paneth cells in response to total-body gamma-irradiation. Related information: Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic Biol Med. 43:397–407, 2007. Spatial coordination of cell adhesion molecules and redox cycling of iron in the microvascular inflammatory response to pulmonary injury. Antioxid Redox Signal. 9:483–95, 2007. Pulmonary biochemical and histological alterations after repeated low-level blast overpressure exposures. Toxicol Sci. 95:289–96, 2007. Friday, October 23: Alexandra C. Miller, PhD, Senior Research Scientist, Radiation Countermeasures Program, AFRRI: Title to be announced. Related information: A review of depleted uranium biological effects: in vitro and in vivo studies. Rev Environ Health 22:75–89, 2007. Leukemic transformation of hematopoietic cells in mice internally exposed to depleted uranium. Mol Cell Biol. 279:97–104, 2005. Suppression of depleted uranium-induced neoplastic transformation of human cells by the phenyl acid, phenyl acetate: Chemoprevention by targeting the p21RAS protein pathway. Radiat Res. 155:163–70, 2001. Friday, October 16: Wan Jiao, MD, PhD, Assistant Professor, Henry M. Jackson Foundation (Combined Injury Program, AFRRI): COX-2 inhibitors are contraindicated for therapy of combined injury. Related information: Aberrant nucleocytoplasmic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentiation. Oncogene 27:3156–3164, 2008. Nucleocytoplasmic shuttling of the retinoblastoma tumor suppressor protein via Cdk phosphorylation-dependent nuclear export. J Biol Chem. 281:38098–38108, 2006. E2F-dependent repression of topoisomerase II regulates heterochromatin formation and apoptosis in cells with melanoma-prone mutation. Cancer Res. 65:4067–4077, 2005. Friday, October 2: Sung-Kee Jo, PhD, Team Head, Radiation Protection Agent Research Team, Director, Radiation Biotechnology Research Division, Korea Atomic Energy Research Institute, Jeonbuk, Republic of Korea: Development of a new herbal composition (HemoHIM) for radioprotection and its application as a supplementary agent for cancer therapy. Related information: Restoration of the immune functions in aged mice by supplementation with a new herbal composition, HemoHIM. Phytother Res. 22: 36–42, 2008. Antiinflammatory activity of an herbal preparation (HemoHIM) in rats. Phytother Res. 21:625–628, 2007. Friday, September 25: Maria Moroni, PhD, Research Associate, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI): Title to be announced. Related information: Pattern of serum immunoreactivity against breast cancer cell lysates may predict severity of disease in breast cancer patients. Cancer Immunol Immunother. 56:1711–1721, 2007. Progressive loss of Syk and abnormal proliferation in breast cancer cells. Cancer Res. 64, 7346–7354, 2004. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway. Oncogene 22:7998–8011, 2003. Friday, September 18: Thomas M. Seed, PhD, Principal Consultant, Tech Micro Services, Bethesda, MD: Canine model for chronic radiation health effects. Related information: CFU-GM colony enhancing activity in sera of dogs under acute and chronic gamma irradiation regimens. Acta Hematol. 71:189–197, 1984. Blood responses under chronic low daily dose gamma irradiation: I. Differential preclinical responses of irradiated male dogs in progression to either aplastic anemia or myeloproliferative disease. Leukemia Res. 13:1069–1084, 1989. Response of hemopoiesis in dogs to continuous low dose rate total body irradiation. Stem Cells 13:261–267, 1995. Friday, September 11: Yufang Shi, PhD, Professor, Department of Molecular Genetics, Microbiology and Immunology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, Piscataway, NJ: NO links mesenchymal stem cells to immunosuppression. Related information: A new trick for an old drug: mTOR Inhibitor rapamycin augments the effect of fluorouracil on hepatocellular carcinoma through inducing cell senescence. Commentary. Cancer Biol Ther. 7:397–398, 2008. Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: Inhibition by an anti-osteopontin monoclonal antibody. J Immunol. 182:2485–2491, 2009. C/EBPbeta mediates synergistic upregulation of gene expression by interferon-gamma and tumor necrosis factor-alpha in bone marrow-derived mesenchymal stem cells. Stem Cells 27:942–948, 2009. Friday, September 4: Merriline M. Satyamitra, PhD, Research Scientist, Henry M. Jackson Foundation) (Radiation Countermeasures Program, AFRRI): Evaluation of radiation countermeasures under NIAID-AFRRI inter agency agreement (IAA). Note: Attendance restricted to AFRRI personnel. Related information: Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells. Mol Cancer Ther. 5:1504–1510, 2006. Tracing radiation induced genomic instability in vivo in the haemopoietic cells from fetus to adult mouse. Br J Radiol. 78:928–933, 2005. Protection against prenatal irradiation-induced genomic instability and its consequences in adult mice by Ocimum flavonoids, orientin and vicenin. Int J Radiat Biol. 80:653–662, 2004. Friday, July 24: Lynnette Cary, PhD, Scientist, Henry M. Jackson Foundation) (Radiation Countermeasures Program, AFRRI): Endothelial cells exposed to neutron/gamma mixed field radiation secrete factors involved in chemotaxis, angiogenesis, and cell survival. Related information: Epidermal growth factor receptor pathway substrate 8 (Eps8) is overexpressed in human pituitary tumors: Role in proliferation and survival. Endocrinology 150:2064–2071, 2008. Bone morphogenetic protein and retinoic acid inducible neural specific protein-3 is expressed in gonadotrope cell pituitary adenomas and induces proliferation, migration and invasion. J. Endocrinology 148:967–75, 2007. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors. Cancer Gene Ther. 13:993–1001, 2006. Friday, July 17: Ian A. Gifford, PhD, Nuclear Engineer, AFRRI: Boron neutron capture therapy at the Maryland University Training Reactor (MUTR). Related information: Experimental validation of the new nanodosimetry-based cell survival model for mixed neutron and gamma-ray irradiation. Phys Med Biol. 52: 367–374, 2007. MUTR fuel bundle reactivity worth. Trans Am Nucl Soc. 96: 407–410, 2007. A high LET neutron irradiation facility for biological samples at the MUTR. Trans Am Nucl Soc. 94: 535–536, 2006. Friday, July 10: Juliann G. Kiang, PhD, Program Advisor, Combined Injury Program, AFRRI: Wound trauma enhanced ionizing radiation-induced mortality: Roles of iNOS, cytokines, and bacterial infection. Related information: Alpha-defensin-like product and asymmetric dimethylarginine increase in mesenteric lymph after hemorrhage in anesthetized rat. Shock. 30:411–946, 2008. Inhibition of inducible nitric oxide synthase protects human T cells from hypoxia-induced injury. Mol Pharmacol. 73:738–747, 2008. Androstenediol inhibits trauma-hemorrhage-induced increase in caspase-3 by downregulating inducible nitric oxide synthase pathway. J App Physiol., 102:933–941, 2007. Friday, June 26: Vijay K. Singh, PhD, Department of Radiation Biology, F. Edward Hebért School of Medicine USUHS; Radiation Countermeasure Program, AFRRI: Progress toward a radiation countermeasure that is effective when initiated days after irradiation. Related information: Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic, as a radiation countermeasure. Immunopharmacol Immunotoxicol. 30: 271–90, 2008. Administration of 5-androstenediol to mice: pharmacokinetics and cytokine gene expression. Exp Mol Pathol. 84:178–188, 2007. Induction of cytokines by radioprotective tocopherol analogs. Expt Mol Pathol. 81:55–61, 2006. Friday, June 12 (noon–1 p.m.): Joseph Mattapallil, PhD, Assistant Professor, Department of Microbiology and Immunology, F. Edward Hebért School of Medicine, USUHS: Host modulation of acute HIV infection: lessons from the non-human primate model. Related information: Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections. J Virol. 82:11589–98, 2008. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to SIV during acute infection. J Immunol. 182:1439–48, 2009. High frequencies of resting CD4+ T cells containing integrated viral dna are found in rhesus macaques during acute lentivirus infection. Proc Natl Acad Sci USA 106:8015–8020, 2009. Friday, May 29: Yogendra Singh, PhD, Visiting Scientist, Bacterial Toxins and Therapeutics Section, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Md.; Scientist G, Institute of Genomics and Integrative Biology, Delhi, India: Protein kinases and phosphatases of mycobacterium tuberculosis. Related information: Loss of kinase activity in Mycobacterium tuberculosis multidomain protein Rv1364c. FEBS J. 275:6295–6308, 2008. Identification, characterization and activation mechanism of a tyrosine kinase of Bacillus anthracis. FEBS J. 275:6237–6247. Spo0B of Bacillus anthracis—a protein with pleiotropic functions. FEBS J. 273:2711–2721, 2008. Friday, May 15: Fung-Lung Chung, PhD, Professor, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC: Lung cancer chemprevention by isothiocyanates: From laboratory to human. Related information: The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res. 67:6409–6416, 2007. Covalent binding to tubulin by isothiocyanates. A mechanism of cell growth arrest and apoptosis. J Biol Chem. 283:22136–22146, 2008. Cancer preventive isothiocyanates induce selective degradation of cellular alpha- and beta-tubulins by proteasomes. J Biol Chem. 2009 284:17039–17051,2009. Friday, May 8: Thomas B. Elliott, PhD, Research Microbiologist, Combined Injury Program, AFRRI: Susceptibility and cytokine responses to infections after ionizing irradiation. Related information: Clindamycin and quinolone therapy for Bacillus anthracis Sterne infection in ⁶⁰Co-gamma-photon-irradiated and sham-irradiated mice. J Antimicrob Chemother. 56:1074–1080, 2005. Comparison of clarithromycin and ciprofloxacin therapy for Bacillus anthracis Sterne infection in mice with or without ⁶⁰Co gamma-photon-irradiation. J Med Microbiol. 54:1157–1162, 2005. Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria. Mol Cell Biochem. 272:29–34, 2005. Friday, May 1: Mukesh Verma, PhD, Chief, Methods and Technologies Branch, Program Director, Epidemiology and Genetics Research Program, Division of Cancer Control and Population Sciences. National Cancer Institute, NIH, Bethesda, Md.: Epigenetics approaches in cancer epidemiology. Related information: Diet, epigenetic events and cancer prevention. Nutrition Reviews 66:S1–S6, 2008. Biomarkers for risk assessment in molecular epidemiology of cancer. Tech Cancer Res Treatment 3:505–514, 2004. Proteomic analysis of the cancer cell mitochondria. Nature Reviews: Cancer 3, 789–795, 2003. Friday, April 24: Sanchita P. Ghosh, PhD, Research Investigator, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI), Bethesda, Md.: Mechanisms of radiation protection by gamma-tocotrienol. Related information: Radiation protection by a new chemical entity Ex-Rad™: Efficacy and mechanisms. Radiation Res. 171:173–179, 2009. The role of cysteines and charged amino acids in extracellular loops of the human Ca²⁺ receptor in cell surface expression and receptor activation processes. Endocrinology 145:3892–3903, 2004. Friday, April 10: Subrata Sinha, MD, PhD, Professor and Head, Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India: Determinants of glial tumor heterogeneity: Molecular features and the microenvironment. Related information: Clonal mutations in primary human glial tumors: Evidence in support of the mutator hypothesis. BMC Cancer 7:190, 2007. Frequent loss of heterozygosity encompassing the hMLH1 locus in low grade astrocytic tumors. J Neurooncol. 81:249–255, 2007. Identification and functional characterization of a novel unspliced transcript variant of HIC-1 in human cancer cells exposed to adverse growth conditions. Cancer Res. 66:10466–10477, 2006. Friday, April 3: Michael Graham Espey, PhD, Staff Scientist, Molecular & Clinical Nutrition Section, Digestive Disease Branch, National Institute of Diabetes Digestive and Kidney Diseases, NIH, Bethesda, Md.: Quercetin and glucose transport in the small intestine. Related information: Plasma membrane cholesterol content affects nitric oxide diffusion dynamics and signaling. J Biol Chem. 283:18513–18521, 2008. Generation of nitroxyl by heme protein-mediated peroxidation of hydroxylamine but not N-hydroxy-L-arginine. Free Rad Biol Med. 45:578–584, 2008. Pharmacologic doses of ascorbate act as a pro-oxidant and decrease growth of aggressive tumor xenografts in mice. Proc Nat Acad Sci USA 105:11105–11109, 2008. Friday, March 27: William F. Blakely, PhD, Program Advisor, Biological Dosimetry, AFRRI: Early biodosimetry response: Recommendations for mass-casualty radiation accidents and terrorism. Related information: BiodosEPR-2006 Meeting: Acute dosimetry consensus committee recommendations on biodosimetry applications in events involving uses of radiation by terrorists and radiation accidents. Radiation Measurements 42:972–996, 2007. Genistein-induced alterations of radiation-responsive gene expression. Radiation Measurements 42:1152–1157, 2007. The use of discriminant analysis for evaluation of early-response multiple biomarkers of radiation exposure using non-human primate 6-Gy whole-body radiation model. Radiation Measurements 42:1158–1163, 2007. Friday, March 20: Gregory L. King, PhD, Research Physiologist, Radiation Infection Treatment Program, AFRRI: The rat as an animal model for radiation-induced GI mucositis. Related information: Early-expression and non-invasive biomarkers of acute radiation syndrome, NATO HFM-099/RTG-099, June 2007, Annual Meeting, Brno, Czech Republic. Sublethal gamma-radiation decreases resistance of mice to oral Shigella sonnei challenge. Microbial Ecol Health Dis. 14: 179–190, 2002. Nuclear, biological, and chemical combined injuries and countermeasures on the battlefield. Mil Med. 167:95–97, 2002. Friday, March 13: John F. Kalinich, PhD, Program Advisor, Internal Contamination and Metal Toxicity Program, AFRRI: Determination of radiation exposure using urinary biomarkers. Related information: Urinary and serum metal levels as indicators of embedded tungsten alloy fragments. Mil Med. 173:754–758, 2008. Embedded weapons-grade tungsten alloy shrapnel rapidly induces metastatic high-grade rhabdomyosarcomas in F344 rats. Environ Health Perspect. 113:729–734, 2005. Depleted uranium-uranyl chloride induces apoptosis in mouse J774 macrophages. Toxicology 179:105–114, 2002. Friday, March 6: Michael R. Landauer, PhD, Research Toxicologist, AFRRI: Radioprotection by genistein: Mechanisms of action. Related information: Genistein induces radioprotection by hematopoietic stem cell quiescence. Int J Radiat Biol. 84:713–726, 2008. Genistein protects against biomarkers of delayed lung sequelae in mice surviving high-dose total body irradiation. J Radiat Res (Tokyo) 49:361–72, 2008. Subcutaneous administration of genistein prior to lethal irradiation supports multilineage, hematopoietic progenitor cell recovery and survival. Int J Radiat Biol. 83: 141–151, 2007. Friday, February 27: G. David Ledney, PhD, Research Biologist, Radiation Combined Injury Program, AFRRI: Combined injury: Treatment and radiation dose determination challenges. Related information: Retrospective analyses of serum lipids and lipoproteins and severity of disease in ⁶⁰Co-irradiated Sus scrofa domestica and Macaca mulatta. Comp Med. 57:298–304, 2007 Medical countermeasures for radiation combined injury: radiation with burn, blast, trauma and/or sepsis. Radiat Res. 169: 712–721, 2008. Antibacterial activity of the soy isoflavone genistein. J Basic Microbiol., 46:329–35, 2006. Friday, February 20: K.S. Kumar, PhD, Research Chemist, Radiation Countermeasures Program, AFRRI: Radiation countermeasure studies with tocols. Related information: Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci. 78:2099–2104, 2006. Induction of cytokines by radioprotective tocopherol analogs. Exp Mol Pathol 81:55–61, 2006. High-dose antibiotic therapy is superior to a 3-drug combination of prostanoids and lipid A derivative in protecting irradiated canines. J Radiat Res (Tokyo) 43:361–370, 2002. Friday, February 13: Pataje G.S. Prasanna, PhD, Research Biologist, AFRRI: Cytogenetic biodosimetry at the Armed Forces Radiobiology Research Institute. Related information: Interlaboratory comparison of the dicentric chromosome assay for radiation biodosimetry in mass casualty events. Radiat Res. 169:551–560, 2008. Sample tracking in an automated cytogenetic biodosimetry laboratory for radiation mass casualties. Radiat Meas. 42:1119–1124, 2007. Early-response biological dosimetry—recommended countermeasure enhancements for mass-casualty radiological incidents and terrorism. Health Phys. 89:494–504, 2005. Friday, February 6: Venkataraman Srinivasan, PhD, Research Biologist, Radiation Countermeasures Program, AFRRI: Delta tocotrienol as a radiation countermeasure. Related information: Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol Immunotoxicol. 30:271–290, 2008. Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxident gamma-tocotrienol. Life Sciences 78:2099–2104, 2006. Genistein treatment protects mice from ionizing radiation injury. J Appl Toxicol. 23:379–385, 2003. Friday, January 30: Anu Puri, PhD, Research Biologist, CCR Nanobiology Program, NIH, NCI-Frederick, Frederick, Md.: Lipid-based nanoparticles for sustained, targeted, and localized delivery of cancer therapeutics. Related information: Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry. Antiviral Res. 80:54–61, 2008. Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion. Mol Membr Biol. 25:83–94, 2008. Evaluation of a nanotechnology-based carrier for delivery of curcumin in prostate cancer cells. Int J Oncol., 32:1119–1123, 2008. Friday, January 23: Richard N. Kolesnick, MD, Associate Member, Molecular Pharmacology and Therapeutics Program, Sloan-Kettering Institute, N.Y.: Radiation-induced GI and bone marrow damage: Two events or three? Related information: Timing of lethality from gastrointestinal syndrome in mice revisited. Int J Oncol Biol Phys. 73:6–8, 2009. Ceramide biogenesis is required for radiation-induced apoptosis in the germ line of Caenorhabditis elegans. Science 322:110–115, 2008. Acid sphingomyelinase involvement in tumor necrosis factor alpha-regulated vascular and steroid disruption during luteolysis in vivo. Proc Natl Acad Sci USA 105:7670–7675, 2008. Friday, January 16: Barrett N. Fountos, MS, Program Manager, Health Scientist, Office of International Health Studies, U.S. Department of Energy, Germantown, Md.: History and relevance of the Russian health studies program. Related information: Letter to the Editor of Health Physics concerning the Department of Energy’s Russian Health Studies Program. Health Physics 93:187–189, 2007.
TOP OF PAGE